USD10
MLTX acciones
Acerca de MoonLakeMoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
USD10
MLTX acciones
Acerca de MoonLakeMoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
26 mar at 13:30 GMT+0
CAPITALIZACIÓN DE MERCADO
1276,76 M US$
PRECIO DE APERTURA
No hay suficientes datos
BAJO (1Y)
5,95 US$
ALTO (1Y)
62,75 US$
BAJO (24H)
16,85 US$
Alza (24H)
18,09 US$
Volumen (24 h)
962,00 US$
99,92 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | No hay suficientes datos | No hay suficientes datos |
1 día | 16,95 US$ | |
1 semana | 16,55 US$ | |
1 mes | 17,93 US$ | |
1 año | 39,84 US$ |